Logo Image
|Articles|November 7, 2022

BGB Group Appoints Fred Bennett As Chief Digital Officer

BGB group, a healthcare advertising, medical education, and strategic consulting agency, announced that Fred Bennett has been named as the firm’s first-ever Chief Digital Officer (CDO).

In his role, Fred will focus on leading and managing the digital teams within BGB Group and strengthening the agency’s long-term plan for leveraging new technologies, innovation, and customer insights to meet client needs in the healthcare industry. Reporting to the agency’s Managing Partners, the CDO will be a key member of the BGB Group executive team.

Continue reading here.

Related to this article

View more
Pharmaceutical Executive Daily
Pharmaceutical Executive Daily: FDA Approves Fayuvi
FDA approves Ultragenyx's Fayuvi as the first treatment for Sanfilippo syndrome type A, Lisata Therapeutics acquires Marea Therapeutics as mAbxience partners with Sandoz on a hemophilia A biosimilar, and Joe Cunningham argues that executive drug-pricing deals alone won't fix costs.
Read more
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance.
Addressing MFN Innovation Concerns
Former U.S. Representative Joe Cunningham (D-SC), spokesperson, Pharmaceutical Reform Alliance. dismisses the pharmaceutical industry's innovation argument against MFN pricing.
Read more